Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainHSR

SP140L SP140

5.15e-055432PS51414
DomainHSR

SP140L SP140

5.15e-055432PF03172
DomainHSR_dom

SP140L SP140

5.15e-055432IPR004865
DomainSAND_dom

SP140L SP140

1.44e-048432IPR000770
DomainSAND

SP140L SP140

1.44e-048432PF01342
DomainSAND

SP140L SP140

1.44e-048432PS50864
DomainSAND

SP140L SP140

1.44e-048432SM00258
Domain-

SP140L SP140

3.37e-04124323.10.390.10
DomainSAND_dom-like

SP140L SP140

3.37e-0412432IPR010919
DomainPHD

KMT2C SP140L SP140

6.84e-0475433PF00628
DomainZnf_PHD-finger

KMT2C SP140L SP140

7.96e-0479433IPR019787
DomainPHD

KMT2C SP140L SP140

1.12e-0389433SM00249
DomainZnf_C2H2_jaz

ZFR ZNF804B

1.16e-0322432IPR022755
Domainzf-C2H2_jaz

ZFR ZNF804B

1.16e-0322432PF12171
DomainZnf_PHD

KMT2C SP140L SP140

1.20e-0391433IPR001965
DomainZF_PHD_2

KMT2C SP140L SP140

1.36e-0395433PS50016
DomainZF_PHD_1

KMT2C SP140L SP140

1.40e-0396433PS01359
DomainCYCLINS

CCNI CCNE2

1.88e-0328432PS00292
DomainCyclin_N

CCNI CCNE2

2.61e-0333432IPR006671
DomainCyclin_N

CCNI CCNE2

2.61e-0333432PF00134
DomainPkinase_C

ROCK2 LATS2

3.28e-0337432IPR017892
DomainBromodomain

SP140L SP140

3.45e-0338432PF00439
DomainCYCLIN

CCNI CCNE2

3.45e-0338432SM00385
Domain-

CCNI CCNE2

3.82e-03404321.10.472.10
DomainBROMODOMAIN_2

SP140L SP140

4.01e-0341432PS50014
DomainPkinase_C

ROCK2 LATS2

4.20e-0342432PF00433
DomainBROMO

SP140L SP140

4.20e-0342432SM00297
DomainBromodomain

SP140L SP140

4.20e-0342432IPR001487
Domain-

SP140L SP140

4.20e-03424321.20.920.10
DomainCyclin-like

CCNI CCNE2

4.40e-0343432IPR013763
DomainZnf_FYVE_PHD

KMT2C SP140L SP140

4.68e-03147433IPR011011
PathwayWP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS

FOXO3 LATS2 YAP1

6.01e-0535313M39430
PathwayWP_MIR302367_PROMOTING_CARDIOMYOCYTE_PROLIFERATION

LATS2 YAP1

1.30e-048312MM15986
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

FOXO3 DENND4A USP54 LATS2 HDAC4 YAP1 GARRE1 PCM1

8.13e-0844644824255178
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

GPATCH2 FASTKD5 BCL11B USP54 REV3L DDX24 GARRE1 RCOR2 PCM1 SP140

1.02e-061116441031753913
Pubmed

YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.

LATS2 YAP1

1.56e-06244230755404
Pubmed

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.

ROCK2 YAP1

1.56e-06244231878963
Pubmed

RPTPε promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.

ROCK2 PTPRE

1.56e-06244231722979
Pubmed

A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response.

LATS2 YAP1

1.56e-06244224525530
Pubmed

Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease.

SP140L SP140

1.56e-06244236130593
Pubmed

Deregulation of Hippo kinase signalling in human hepatic malignancies.

LATS2 YAP1

1.56e-06244222098159
Pubmed

Epigenetic reader SP140 loss of function drives Crohn's disease due to uncontrolled macrophage topoisomerases.

SP140L SP140

1.56e-06244235952671
Pubmed

Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2.

ROCK2 YAP1

1.56e-06244228686514
Pubmed

The role of Sp140 revealed in IgE and mast cell responses in Collaborative Cross mice.

SP140L SP140

1.56e-06244234156030
Pubmed

The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.

BCL11B LATS2 YAP1

3.75e-062444330523785
Pubmed

Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse.

FOXO3 LATS2 YAP1

4.26e-062544319786569
Pubmed

Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

LATS2 YAP1

4.69e-06344221278236
Pubmed

Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.

LATS2 YAP1

4.69e-06344221832154
Pubmed

Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.

LATS2 YAP1

4.69e-06344232186675
Pubmed

Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung.

LATS2 YAP1

4.69e-06344232534707
Pubmed

Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations.

LATS2 YAP1

4.69e-06344227128293
Pubmed

RNA-binding protein Dnd1 inhibits epithelial-mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells.

LATS2 YAP1

4.69e-06344228593479
Pubmed

microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway.

LATS2 YAP1

4.69e-06344224779718
Pubmed

ZIP4 upregulation aggravates nucleus pulposus cell degradation by promoting inflammation and oxidative stress by mediating the HDAC4-FoxO3a axis.

FOXO3 HDAC4

4.69e-06344238217540
Pubmed

Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.

LATS2 YAP1

4.69e-06344218413746
Pubmed

Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73.

LATS2 YAP1

4.69e-06344218565851
Pubmed

LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.

LATS2 YAP1

4.69e-06344225973055
Pubmed

The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.

LATS2 YAP1

4.69e-06344231990985
Pubmed

m6 A demethylase ALKBH5 drives denervation-induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling.

FOXO3 HDAC4

4.69e-06344235142084
Pubmed

RNF106 aggravates esophageal squamous cell carcinoma progression through LATS2/YAP axis.

LATS2 YAP1

4.69e-06344237207933
Pubmed

Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

LATS2 YAP1

4.69e-06344218158288
Pubmed

Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons.

SP140L SP140

9.37e-06444234151776
Pubmed

Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.

LATS2 YAP1

9.37e-06444228754671
Pubmed

The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner.

LATS2 YAP1

9.37e-06444233368671
Pubmed

Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.

LATS2 YAP1

9.37e-06444221041411
Pubmed

Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.

LATS2 YAP1

9.37e-06444220841485
Pubmed

Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.

LATS2 YAP1

9.37e-06444226598551
Pubmed

Hippo signaling pathway reveals a spatio-temporal correlation with the size of primordial follicle pool in mice.

LATS2 YAP1

9.37e-06444225659841
Pubmed

Hippo signaling instructs ectopic but not normal organ growth.

LATS2 YAP1

9.37e-06444236395225
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

FOXO3 DENND4A ARHGEF4 USP54 HDAC4 YAP1 GARRE1 PCM1

1.10e-0586144836931259
Pubmed

Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.

LATS2 YAP1

1.56e-05544224106267
Pubmed

Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).

LATS2 YAP1

1.56e-05544218640976
Pubmed

The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis.

LATS2 YAP1

1.56e-05544236229481
Pubmed

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway.

LATS2 YAP1

1.56e-05544232994166
Pubmed

Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases.

LATS2 YAP1

1.56e-05544219919647
Pubmed

Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis.

LATS2 YAP1

1.56e-05544235191398
Pubmed

Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.

LATS2 YAP1

1.56e-05544226109051
Pubmed

Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi.

LATS2 YAP1

1.56e-05544232796823
Pubmed

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.

LATS2 YAP1

1.56e-05544228973878
Pubmed

Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.

LATS2 YAP1

1.56e-05544229438698
Pubmed

The Hippo Pathway Blocks Mammalian Retinal Müller Glial Cell Reprogramming.

LATS2 YAP1

1.56e-05544231067451
Pubmed

YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation.

LATS2 YAP1

1.56e-05544228805663
Pubmed

Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis.

LATS2 YAP1

2.34e-05644231558567
Pubmed

Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.

LATS2 YAP1

2.34e-05644224101513
Pubmed

Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell.

LATS2 YAP1

2.34e-05644231019301
Pubmed

Activation of the intrinsic fibroinflammatory program in adult pancreatic acinar cells triggered by Hippo signaling disruption.

LATS2 YAP1

2.34e-05644231513574
Pubmed

The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.

LATS2 YAP1

2.34e-05644221041410
Pubmed

Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.

LATS2 YAP1

2.34e-05644229689192
Pubmed

Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.

LATS2 YAP1

2.34e-05644230266805
Pubmed

cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.

LATS2 YAP1

2.34e-05644223644383
Pubmed

Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass.

LATS2 YAP1

2.34e-05644238811804
Pubmed

The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass.

LATS2 YAP1

2.34e-05644219289085
Pubmed

Development of a screening set for new (CAG/CTG)n dynamic mutations.

PTPRE MN1

2.34e-0564428786123
Pubmed

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas.

LATS2 YAP1

2.34e-05644236443313
Pubmed

YAP Mediates Hair Cell Regeneration in Balance Organs of Chickens, But LATS Kinases Suppress Its Activity in Mice.

LATS2 YAP1

2.34e-05644232341094
Pubmed

YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.

LATS2 YAP1

3.27e-05744229669762
Pubmed

YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice.

LATS2 YAP1

3.27e-05744232900774
Pubmed

YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression.

LATS2 YAP1

3.27e-05744231801083
Pubmed

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.

LATS2 YAP1

3.27e-05744231754005
Pubmed

Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling.

LATS2 YAP1

3.27e-05744232960816
Pubmed

YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.

LATS2 YAP1

3.27e-05744230582452
Pubmed

Deficiency of large tumor suppressor kinase 1 causes congenital hearing loss associated with cochlear abnormalities in mice.

LATS2 YAP1

3.27e-05744233162027
Pubmed

YAP1/TAZ drives ependymoma-like tumour formation in mice.

LATS2 YAP1

3.27e-05744232404936
Pubmed

Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.

LATS2 YAP1

3.27e-05744224225952
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

TMEM131L UBE2J1 FASTKD5 USP54 GFM1 YAP1 PCM1

3.49e-0573344734672954
Pubmed

YAP maintains the production of intermediate progenitor cells and upper-layer projection neurons in the mouse cerebral cortex.

BCL11B YAP1

4.36e-05844234931379
Pubmed

Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription.

LATS2 YAP1

4.36e-05844232259481
Pubmed

D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain.

FOXO3 BCL11B

4.36e-05844234556581
Pubmed

A Stk4-Foxp3-NF-κB p65 transcriptional complex promotes Treg cell activation and homeostasis.

LATS2 YAP1

4.36e-05844236149942
Pubmed

Hippo pathway-dependent and -independent roles of RASSF6.

LATS2 YAP1

4.36e-05844219797269
Pubmed

Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

LATS2 YAP1

4.36e-05844225026211
Pubmed

AMOTL2 mono-ubiquitination by WWP1 promotes contact inhibition by facilitating LATS activation.

LATS2 YAP1

4.36e-05844234404733
Pubmed

Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors.

FOXO3 BCL11B

4.36e-05844222935140
Pubmed

Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development.

LATS2 YAP1

5.60e-05944227160901
Pubmed

Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.

NCOA1 HDAC4

5.60e-05944215184363
Pubmed

Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis.

SP140L SP140

5.60e-05944238029747
Pubmed

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

LATS2 YAP1

5.60e-05944222863277
Pubmed

The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

LATS2 YAP1

5.60e-05944220643348
Pubmed

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation.

LATS2 YAP1

5.60e-05944236828627
Pubmed

Human transcription factor protein interaction networks.

NCOA1 KMT2C ZFR USP54 DDX24 YAP1 LIN9 GARRE1 PCM1

6.28e-05142944935140242
Pubmed

SDCCAG8 regulates pericentriolar material recruitment and neuronal migration in the developing cortex.

BCL11B PCM1

6.99e-051044225088364
Pubmed

Interaction network of human early embryonic transcription factors.

NCOA1 KMT2C BCL11B HDAC4 LIN9

8.00e-0535144538297188
Pubmed

Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex.

BCL11B YAP1

8.54e-051144234999833
Pubmed

Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.

LATS2 YAP1

8.54e-051144233515576
Pubmed

LATS1/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation.

LATS2 YAP1

8.54e-051144236125128
Pubmed

Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells.

LATS2 YAP1

8.54e-051144229849151
Pubmed

The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.

LATS2 YAP1

8.54e-051144228492365
Pubmed

Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.

LATS2 YAP1

8.54e-051144228486106
Pubmed

Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.

DENND4A HDAC4 YAP1 PCM1

9.87e-0519044415161933
Pubmed

WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.

LATS2 YAP1

1.02e-041244235429439
Pubmed

Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.

LATS2 YAP1

1.02e-041244225438054
Pubmed

The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1.

LATS2 YAP1

1.02e-041244235027733
Pubmed

MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.

LATS2 YAP1

1.21e-041344233571521
GeneFamilyPHD finger proteins

KMT2C SP140L SP140

3.20e-049027388
GeneFamilyCyclins

CCNI CCNE2

7.93e-0428272473
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

TMEM131L NCOA1 KMT2C ZFR DENND4A BCL11B REV3L PTPRE DDX24 CCNI PCM1 VAMP1 SP140

6.17e-0714924413M40023
CoexpressionBLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN

ROCK2 ZFR DENND4A ARHGEF4 VAMP1

8.53e-06166445M6110
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

ROCK2 FOXO3 TMEM131L NCOA1 REV3L HDAC4 MN1 YAP1 GARRE1

1.03e-05856449M4500
CoexpressionGSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP

GPATCH2 KMT2C MN1 PNOC VAMP1

2.10e-05200445M3523
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B SPATS2L MN1 PNOC ZNF804B

7.29e-091484465e738522d4ad35e08bc4ff8c41b7bea38ec6ef95
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

TMEM131L KMT2C DENND4A BCL11B HDAC4 PCM1

3.44e-0819244647646d7e4990be85072987f92bf18d52f8da752e
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

BCL11B CUBN MN1 PNOC ZNF804B

1.15e-06188445ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMP5 BCL11B MN1 CCDC85A PNOC

1.24e-06191445fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCellwk_20-22-Hematologic_Lymphocytic-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

TMEM131L UBE2J1 LAMP5 PNOC SP140

1.34e-06194445aca97fbf1a932df457a82709c2a2dc9081e018df
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCOA1 KMT2C ZFR REV3L PCM1

1.38e-061954453e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCOA1 KMT2C ZFR REV3L PCM1

1.38e-061954457796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellsevere_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2)

BCL11B CUBN MN1 LIN9

1.24e-05144444c7f696e55e2d959c58ec32640c71ef86ee25203c
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC ZNF804B

1.53e-051524448ff5a178a8f3550d89a003c0858820aab3773386
ToppCelltumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

TMEM131L DENND4A PNOC SP140

1.61e-05154444e16f200391537aa1002b0079481b94e1fb86b9ad
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B LATS2 PNOC

1.74e-05157444516903469756c5fabfdf56d7bd59b3bdd7b44e39
ToppCellBronchial_Biopsy-Immune-B_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

UBE2J1 LAMP5 PNOC SP140

2.16e-0516644422e94546b264c87cb55928d1591bf1b5ee2a76bd
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

DENND4A BCL11B DDX24 PCM1

2.43e-051714442e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellChildren_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

TMEM131L UBE2J1 PNOC SP140

2.90e-0517944431411780f1a44bf2d102f288416e97eacec4b6b6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FOXO3 UBE2J1 PNOC SP140

3.03e-051814446cdee2f56bc633b387b4dbbd78c624edbd712c24
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FOXO3 UBE2J1 PNOC SP140

3.03e-05181444b75b8b025257bccfe661fd0f92ab284b2a9c12ee
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMP5 MN1 CCDC85A PNOC

3.37e-05186444310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

BCL11B CUBN MN1 PNOC

3.44e-05187444d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMP5 BCL11B CCDC85A PNOC

3.59e-05189444f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCellMS-pDC|MS / Condition, Cell_class and T cell subcluster

UBE2J1 LAMP5 PTPRE PNOC

3.67e-05190444f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f
ToppCellMS-pDC-|MS / Condition, Cell_class and T cell subcluster

UBE2J1 LAMP5 PTPRE PNOC

3.67e-05190444f56ec302d556ace4f7609017a35c311cf43aa8a5
ToppCellcellseq2-Immune-Lymphocytic_B-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UBE2J1 LAMP5 PNOC SP140

3.74e-0519144417746a32f723c078aba1f7e320b0e3f1ab8bf5c6
ToppCellcellseq2-Immune-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UBE2J1 LAMP5 PNOC SP140

3.74e-05191444c2c450df810f83163987cd0f7ed9b50025cd3de1
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMP5 BCL11B MN1 PNOC

3.74e-051914447b386512284dfaa0e95358b28ee82632ee965e64
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

UBE2J1 LAMP5 PTPRE PNOC

3.98e-051944443f9e4a8e5699bc379e8a0d337e0daef09632e71c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

UBE2J1 LAMP5 PTPRE PNOC

3.98e-051944445250736b608001fb73aa74dee8cb8465a1d2f372
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

UBE2J1 LAMP5 PNOC SP140

4.06e-051954446da69e3eba036936f44bc052996ad12b6309055e
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DENND4A BCL11B DDX24 PCM1

4.06e-05195444ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

UBE2J1 LAMP5 PNOC SP140

4.06e-05195444df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

BCL11B SP140L DDX24 SP140

4.14e-05196444c225c8eb2fe9a10f0cf574c7d8b6206887aac2df
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

KMT2C BCL11B DDX24 PCM1

4.22e-0519744457ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellTCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

ZFR DENND4A CCNI PCM1

4.30e-05198444af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCellTCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

ZFR DENND4A CCNI PCM1

4.30e-0519844462cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCellTCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9

ZFR DENND4A CCNI PCM1

4.30e-05198444ad39cce004867f083f8da1954e0cf5a263815184
ToppCellCOVID-19_Moderate|World / disease group, cell group and cell class

BCL11B SP140L DDX24 SP140

4.39e-05199444952fac67588ad5676f5939e3c7f8bac803c27064
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type.

ATP6V1G2 BCL11B CCNI MN1

4.48e-0520044484e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic

BCL11B CUBN MN1 PNOC

4.48e-05200444c74bc12e13d002dedaaf75a2244ec111e47524e1
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic

BCL11B CUBN MN1 PNOC

4.48e-05200444ead9eb579bb25fde05fc15602e3d05ab6617f7ac
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic

LAMP5 BCL11B MN1 PNOC

4.48e-05200444d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic

LAMP5 BCL11B MN1 PNOC

4.48e-05200444862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic

LAMP5 BCL11B MN1 PNOC

4.48e-05200444a91345f268f13170c27309333603eb82400c9947
ToppCell(09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint

MN1 RCOR2 POLR3F

1.75e-04110443fce7d5a0617fc664b657f5bb9abb290e7cc234cb
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC

2.26e-04120443a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a
ToppCellLPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ATP6V1G2 BCL11B VAMP1

2.61e-0412644354247ce9ee0a4f123f1fb225600a4ec698510a86
ToppCelldroplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TMEM25 USP54 YAP1

2.99e-0413244314a512f433315892bf0326419f23d0d5919d01ec
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PTPRE PNOC ZNF804B

3.56e-041404432c44e8cc5190226049be7ebc465d685393e701c4
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B ZNF804B

3.63e-0414144340ef6d792e11fe10963d64eb0b606b90556c1a70
ToppCellsevere_COVID-19-B_cell|World / disease group, cell group and cell class (v2)

CUBN MN1 LIN9

3.78e-0414344328b0e168126a9fe60541dc12bfab385b7a0a2342
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC

4.52e-04152443fed80b467ec9e30c7f98bed6cc4f8c583b715e9e
ToppCelltumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|tumor_Lung / Location, Cell class and cell subclass

UBE2J1 CCDC85A PNOC

4.88e-04156443b5851474ba14dd2b4867415828b52dd98ecdd6d3
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXO3 VAMP1 SP140

4.97e-04157443d8e283414a770f05d71f0455d0822e9a9660b115
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXO3 VAMP1 SP140

4.97e-04157443165e98bf944572cafbc06ef43c9eab7bd6bea1c2
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC

5.16e-041594430dccc4275b9b4f8554dd556da7218e130bff8fd1
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

ATP6V1G2 BCL11B GABRA4

5.25e-041604438e2b51d7b42e0b6e62641efdbbc73d31561d6a3e
ToppCellLAM-Lymphoid-B-cell-2|LAM / Condition, Lineage and Cell class

UBE2J1 LAMP5 PNOC

5.25e-041604430060c2b3304f411c682aa2ba20bcf80f346d2403
ToppCellMild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass

LAMP5 RCOR2 PNOC

5.25e-04160443aa79848913910c01249d6cacf4ed53ec0e4f5c3d
ToppCellMild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass

LAMP5 RCOR2 PNOC

5.25e-041604437fdb849f5caf5a127a2582326215e11f8eb4fa0e
ToppCellHealthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2)

BCL11B CUBN NT5C1B

5.35e-041614438a61395af33132783a0a37956c6f821aba5d3b1e
ToppCellfacs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP6V1G2 ARHGEF4 ZNF804B

5.35e-0416144369f5e759c0925daa37e0177a9cc3154842906bf6
ToppCellLAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class

LAMP5 PTPRE PNOC

5.35e-04161443bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

UBE2J1 LAMP5 PNOC

5.45e-04162443ee6f05620f4f4ebbebd5b098afc7c20876e3d21f
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

TMEM131L BCL11B NT5C1B

5.45e-04162443b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM131L PNOC SP140

5.45e-04162443b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

UBE2J1 LAMP5 PNOC

5.45e-041624439e72d468fcdd0d27b517a9e36efb35d4617a88f9
ToppCelldroplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPRE RCOR2 SP140

5.45e-0416244393bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC

5.54e-04163443bba830a302919c8b33f914a8839877fc21dd28a0
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC

5.54e-041634438d17f44faf0549fe71a9a45f811f50d767275414
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LAMP5 BCL11B PNOC

5.64e-0416444308819970174a3eb4eee8e1e675075828665b845e
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ATP6V1G2 BCL11B VAMP1

5.74e-04165443cced77f2d74b07010307d7f4788b8cf3fdaeb91a
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ATP6V1G2 BCL11B VAMP1

5.74e-041654430c80abf13409767825ef8a507b498afafa7e89c5
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NT5C1B PNOC SP140

5.85e-04166443a8ba4d51e778634f8a7f47fa0d01a2019f774fb8
ToppCellCOVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster

TMEM131L LIN9 VAMP1

5.85e-041664434ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NT5C1B PNOC SP140

5.85e-041664434906c85f52c3751166e296102d524a13b1f438f5
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-plasma_cell-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

UBE2J1 GABRA4 SP140

5.85e-04166443139bf49eb3624d9eec7e8a2cb33d69716d63a7c5
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NT5C1B PNOC SP140

5.85e-0416644304e32bd32165cdf316f2a8709c3662d55cd70391
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

UBE2J1 GABRA4 SP140

5.85e-0416644385f59c3cc7db8863ec0044f1fcc14580834f830b
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBE2J1 GABRA4 SP140

6.05e-0416844341da200bbff5c663c39f67c38d6d5f43b0ad9494
ToppCellmetastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

TMEM25 LAMP5 PNOC

6.05e-041684434bf3f85aac4b335efa93d22c9ce7b153cb5ce152
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NT5C1B PNOC SP140

6.05e-041684430ecc6503ea249a4b13c42cfec2b024338f7e6080
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBE2J1 GABRA4 SP140

6.05e-04168443a77259c13508f19186d7b0f80b34dc6d89497ab5
ToppCellHealthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass

LAMP5 RCOR2 PNOC

6.16e-04169443a4e9b8b2f0338203455ba941b8f99bf4884d26f0
ToppCellmetastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass

LAMP5 PTPRE PNOC

6.16e-0416944371f6761b9927f352e0ccc221ca373319915f4184
ToppCellBronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

LAMP5 PNOC SP140

6.16e-04169443dc388f660f69e37e517bf3243daf071ab138ee6e
ToppCellHealthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

LAMP5 RCOR2 PNOC

6.16e-04169443338ce99897cb522b86edd603f75bc15ec4dfcda3
ToppCell3'-Adult-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TMEM131L CCDC85A VAMP1

6.16e-04169443203971cceeba150d0e8891c92662545e84c77837
ToppCellControl-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations)

USP54 PTPRE CCDC85A

6.26e-04170443e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCellURO-Lymphocyte-B-B_intermediate|URO / Disease, Lineage and Cell Type

CCDC85A PNOC SP140

6.26e-04170443e11d1510518cedabeece96d4adbb90999e6326fa
ToppCelldroplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUBN GABRA4 SP140

6.26e-0417044329deb285d5a82c0abcc108012ca42f4b4b4d9e19
ToppCelldroplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUBN GABRA4 SP140

6.26e-04170443dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2
ToppCelldroplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCOA1 YAP1 PNOC

6.37e-04171443a474aaed3ca4cacb0ab565c35f25d92a10f531b7
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMP5 PTPRE PNOC

6.37e-041714434fd2c7977c512c51507f055fc74b111c0228ed8b
ToppCelldroplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCL11B GABRA4 SP140

6.48e-04172443226de1a5d4a360d3ae01b0235fea19521ec623a0
ToppCell5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM131L PNOC SP140

6.48e-04172443172e3c78f8e97988a4fd8624514e731282ddc16d
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CCNE2 GARRE1 CCDC85A

6.48e-04172443490745024730df6357f6c2b81d7a64e21557c0d5
ToppCell5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM131L PNOC SP140

6.48e-041724435fb0ea6145892a258696197b3feed9760187e712
ToppCell5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM131L PNOC SP140

6.48e-041724432214cc37d7c21b868768d3f74ca4631d339d37b3
ToppCell5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM131L PNOC SP140

6.48e-0417244307620728a6cdeea805e1365e588be096c17a370c
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

UBE2J1 FASTKD5 CCDC85A

6.59e-0417344309cd878c33534bd476d6a4880f5582076189da8c
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

YAP1 CCNE2 CCDC85A

6.59e-0417344312f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCellwk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

MN1 CCDC85A VAMP1

6.59e-04173443b23b408acc29a667cce104429afef1a6cf2720a5
DrugTolnaftate [2398-96-1]; Down 200; 13uM; PC3; HG-U133A

NCOA1 COX10 FASTKD5 CCNE2 PCM1 VAMP1

2.15e-061984461919_DN
Diseasepeak expiratory flow

FOXO3 NCOA1 SPATS2L HDAC4 MN1 NT5C1B

9.19e-05498446EFO_0009718
DiseaseMalignant neoplasm of breast

TMEM25 NCOA1 ARHGEF4 USP54 CUBN HDAC4 YAP1 GABRA4

1.66e-041074448C0006142
Diseaseupper face morphology measurement

BCL11B SP140L SP140

4.14e-0497443EFO_0010949
Diseasesolar lentigines measurement

TMEM131L NT5C1B

1.05e-0332442EFO_0007850
DiseaseNecrotizing encephalopathy, infantile subacute, of Leigh

COX10 GFM1

1.33e-0336442C2931891
DiseaseLeigh Syndrome due to Mitochondrial Complex V Deficiency

COX10 GFM1

1.33e-0336442C1850600
DiseaseLeigh Syndrome due to Mitochondrial Complex III Deficiency

COX10 GFM1

1.33e-0336442C1850598
DiseaseLeigh Syndrome Due To Mitochondrial Complex II Deficiency

COX10 GFM1

1.33e-0336442C1850597
DiseaseLeigh Syndrome due to Mitochondrial Complex IV Deficiency

COX10 GFM1

1.33e-0336442C1850599
Diseaseneurodegenerative disease (implicated_via_orthology)

BCL11B LATS2 YAP1

1.33e-03145443DOID:1289 (implicated_via_orthology)
DiseaseLEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY

COX10 GFM1

1.40e-0337442C1838951
Diseaseprostate cancer (is_marker_for)

FOXO3 NCOA1 KMT2C

1.64e-03156443DOID:10283 (is_marker_for)
Diseaseornithine measurement

HDAC4 ZNF804B

1.98e-0344442EFO_0009776
Diseaseserum non-albumin protein measurement

TMEM131L SP140L YAP1 SP140

2.03e-03361444EFO_0004568
Diseasedimethylglycine measurement

COX10 ZNF804B

2.16e-0346442EFO_0010476
DiseaseLeigh Disease

COX10 GFM1

2.25e-0347442C0023264
DiseaseSquamous cell carcinoma of the head and neck

YAP1 CCNE2

2.75e-0352442C1168401
Diseasereaction time measurement

FOXO3 NCOA1 SPATS2L CCDC85A RFPL3

2.88e-03658445EFO_0008393
Diseaseresponse to efavirenz, virologic response measurement

BCL11B PCM1

3.41e-0358442EFO_0006904, EFO_0006906
Diseasechronic obstructive pulmonary disease

BCL11B SPATS2L HDAC4 MN1 PCM1

3.48e-03688445EFO_0000341
Diseasecarcinoma (implicated_via_orthology)

LATS2 YAP1

4.13e-0364442DOID:305 (implicated_via_orthology)
DiseaseIntellectual Disability

KMT2C BCL11B HDAC4 MN1

4.37e-03447444C3714756
DiseaseCleft palate

YAP1 PCM1

5.06e-0371442HP_0000175

Protein segments in the cluster

PeptideGeneStartEntry
ATRRQVQGMQSSQQR

ATP6V1G2

76

O95670
RLSNQMRRAVNPNHS

NT5C1B

36

Q96P26
LTRVTQPQAKSQQRM

ARHGEF4

506

Q9NR80
MSRRSSRLQAKQQPQ

CCNE2

1

O96020
VRKMPSNQNVSPSQR

CCNI

31

Q14094
SNMNRTKNRPLVRGQ

COX10

216

Q12887
QNPKRIQRMNSSFSV

DENND4A

1141

Q7Z401
RQVQSMKQTNSSLRQ

RCOR2

296

Q8IZ40
FVSRIRNQRPQMVQT

PTPRE

366

P23469
MKRQQQQDSIDPSSR

KMT2C

1716

Q8NEZ4
QQRPNANAVRSMEKV

HDAC4

1006

P56524
QINTRSPKRNQRVAM

LIN9

71

Q5TKA1
DATRQQQQMRATPKF

LATS2

56

Q9NRM7
RPLAKTRQQNISMQR

PCM1

966

Q15154
KMTANQVQIPRDRSQ

LAMP5

261

Q9UJQ1
PLQNTNANLNMRKRT

GABRA4

376

P48169
MQSSQRRRTLHQNGN

PNOC

161

Q13519
QRQKRSINLQQPRMA

CUBN

31

O60494
QTPRMKLAVQFTNRN

FASTKD5

691

Q7L8L6
MSRRKQGNPQHLSQR

BCL11B

1

Q9C0K0
QAMQQKRQAQHGRRP

GARRE1

856

O15063
SQNRRQPPTRNSSNM

CCDC85A

441

Q96PX6
STQKQQRMLNRRPEI

DDX24

426

Q9GZR7
MISVQQRNQPSRVRS

CCDC168

5631

Q8NDH2
MLVAKRRPSSNLNNN

GPATCH2

121

Q9NW75
SNPARALQQMRSKLN

GFM1

181

Q96RP9
MASRNQQQRLRQPNL

MN1

561

Q10571
SAQNSRRNVMLRNDP

FOXO3

501

O43524
PNMTSNRRLQQTQAQ

VAMP1

26

P23763
TMPANKQNGSSNQRR

SPATS2L

421

Q9NUQ6
MKTRQRQNASSSSQQ

TMEM131L

901

A2VDJ0
LRQMSSQNSPSRLNI

NCOA1

561

Q15788
RESKQNPMIQRNSSF

POLR3F

196

Q9H1D9
SRMGTRTQKNNQQND

SP140L

221

Q9H930
QRSTMPNRHQLQSDR

ZNF804B

181

A4D1E1
RRRNRNETSQMSQPE

REV3L

271

O60673
LRQAMRNINPSTANS

YAP1

326

P46937
KNTSMSPRQRRAQQQ

UBE2J1

246

Q9Y385
SMKIQQNQSIRRPSR

ROCK2

1366

O75116
CSMVSQRNKIRPNRQ

RFPL3

81

O75679
PQMSQRFNIHNNRKR

ZFR

1036

Q96KR1
RMRRQENSQQNDNSK

SP140

511

Q13342
SRAVKPADRQMAQNN

TMEM25

311

Q86YD3
RKARSLQDRMQQQQS

USP54

856

Q70EL1